U.S. market Closed. Opens in 25 minutes

BCTXW | BriaCell Therapeutics Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-07-312023-07-312022-07-312021-07-312020-07-312019-07-312018-07-31
RevenueN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/A
Operating Expenses33.33M23.27M-3.39K-3.69M-1.38M-946.42K-1.07M
Selling, General & Admin6.15M7.94M7.27M-3.67M-1.37M-932.17K-1.05M
Research & Development27.18M15.34M8.02M1.32M2.22M3.74M2.39M
Other Operating ExpensesN/AN/AN/AN/A-58.98K319.86K-312.92K
Operating Income-4.79M-23.27M-15.29M-6.97M-3.61M-4.73M-3.82M
Other Expenses / IncomeN/A2.08M-30.73K6.58M-72.25K343.74K-331.40K
Before Tax Income-4.79M-20.30M-11.55M3.69M1.38M946.42K1.07M
Income Tax ExpensesN/A-152.62K979.006.58M-72.25K343.74K1.59M
Net Income-4.79M-20.30M-11.55M3.69M1.38M946.42K1.07M
Interest ExpensesN/AN/A979.0046.09K27.00K23.82K15.63K
Basic Shares Outstanding16.45M15.52MN/AN/AN/AN/A427.81K
Diluted Shares Outstanding16.45M15.52MN/AN/AN/AN/A427.81K
EBITDA-4.79M-22.37M-11.50M3.71M1.40M960.68K1.08M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-4.79M-20.46M-11.55M10.32M1.34M1.31M2.67M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2024-07-312023-07-312022-07-312021-07-312020-07-312019-07-312018-07-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙